John D. Quisel, SVP, Corporate Development, GC & Secretary at ACCELERON PHARMA INC (XLRN), sold 8,666 shares at $42.42 ($368K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $368k XLRN by SVP, Corporate Development, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.42 | 4,333 | $184K | 50.0% |
| 2 | $42.42 | 4,333 | $184K | 50.0% |
| Total | $42.42 avg | 8,666 | $368K | 100% |
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |